|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
ELV056621612 |
| 003 |
DE-627 |
| 005 |
20230624233221.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
220205s2022 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.earlhumdev.2021.105522
|2 doi
|
| 028 |
5 |
2 |
|a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001656.pica
|
| 035 |
|
|
|a (DE-627)ELV056621612
|
| 035 |
|
|
|a (ELSEVIER)S0378-3782(21)00221-8
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 082 |
0 |
4 |
|a 610
|q VZ
|
| 082 |
0 |
4 |
|a 610
|q VZ
|
| 084 |
|
|
|a 44.45
|2 bkl
|
| 100 |
1 |
|
|a Liu, Yu-Mei
|e verfasserin
|4 aut
|
| 245 |
1 |
4 |
|a The clinical value of ultrasonic cardiac output monitor in very-low birth-weight and extremely-low-birth-weight infants undergoing PDA ligation
|
| 264 |
|
1 |
|c 2022
|
| 336 |
|
|
|a nicht spezifiziert
|b zzz
|2 rdacontent
|
| 337 |
|
|
|a nicht spezifiziert
|b z
|2 rdamedia
|
| 338 |
|
|
|a nicht spezifiziert
|b zu
|2 rdacarrier
|
| 520 |
|
|
|a Cardiorespiratory instability occurs very often in very-low-birth-weight (VLBW) and extremely-low-birth-weight (ELBW) infants undergoing patent ductus arteriosus (PDA) ligation during the early postoperative period. This study aimed to investigate ultrasonic cardiac output monitor (USCOM) as a bedside tool by evaluating the hemodynamic changes in preterm infants following PDA ligation and assessing factors that may influence these changes.
|
| 700 |
1 |
|
|a Zheng, Man-Li
|4 oth
|
| 700 |
1 |
|
|a Sun, Xin
|4 oth
|
| 700 |
1 |
|
|a Chen, Xiao-Bo
|4 oth
|
| 700 |
1 |
|
|a Sun, Yun-Xia
|4 oth
|
| 700 |
1 |
|
|a Feng, Zhi-Chun
|4 oth
|
| 700 |
1 |
|
|a He, Shao-Ru
|4 oth
|
| 773 |
0 |
8 |
|i Enthalten in
|n Elsevier Science
|a Abdel-Aziz, Tarek Ezzat ELSEVIER
|t Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics
|d 2014
|g Amsterdam [u.a.]
|w (DE-627)ELV022803173
|
| 773 |
1 |
8 |
|g volume:165
|g year:2022
|g pages:0
|
| 856 |
4 |
0 |
|u https://doi.org/10.1016/j.earlhumdev.2021.105522
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_U
|
| 912 |
|
|
|a GBV_ELV
|
| 912 |
|
|
|a SYSFLAG_U
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a GBV_ILN_130
|
| 912 |
|
|
|a GBV_ILN_350
|
| 936 |
b |
k |
|a 44.45
|j Immunologie
|q VZ
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 165
|j 2022
|h 0
|